Details for Patent: 8,796,299
Summary for Patent: 8,796,299
| Title: | NK1 antagonists |
| Abstract: | A NK1 antagonist having the formula (I), |
| Inventor(s): | Sunil Paliwal, Gregory A. Reichard, Cheng Wang, Dong Xiao, Hon-Chung Tsui, Neng-Yang Shih, Juan D. Arredondo, Michelle Laci Wrobleski, Anandan Palani |
| Assignee: | Merck Sharp and Dohme LLC , Opko Health Inc |
| Application Number: | US13/625,799 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,796,299
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,796,299
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1463716 | ⤷ Start Trial | 300895 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1463716 | ⤷ Start Trial | CR 2017 00041 | Denmark | ⤷ Start Trial |
| European Patent Office | 1463716 | ⤷ Start Trial | PA2017032 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
